[صفحه اصلی ]   [Archive]  
:: صفحه اصلي :: درباره نشريه :: آخرين شماره :: تمام شماره‌ها :: جستجو :: ثبت نام :: ارسال مقاله :: تماس با ما ::
بخش‌های اصلی
آرشیو مجله و مقالات::
برای نویسندگان::
برای داوران::
ثبت نام و اشتراک::
تماس با ما::
تسهیلات پایگاه::
بایگانی مقالات زیر چاپ::
::
جستجو در پایگاه

جستجوی پیشرفته
..
:: دوره 17، شماره 1 - ( 5-1402 ) ::
جلد 17 شماره 1 صفحات 33-26 برگشت به فهرست نسخه ها
Clinical Findings and Mortality Rate of Patients with Multiple Myeloma Following COVID-19 infection: Report from Iranian Network for Research in Viral Diseases (INRVD)
چکیده:   (445 مشاهده)
Abstract
Background and Aims: COVID-19 is a viral disease that spreads easily, caused by the SARS-CoV-2 virus. This illness has led to a worldwide pandemic and has caused many human fatalities. Patients with cancer have a weakened immune system, which makes them more susceptible to various infections. In this research, we wanted to compare mortality, hospitalization rate, and clinical findings in multiple myeloma (MM) patients.
Materials and Methods: This research examined the effect of COVID-19 on sixteen individuals diagnosed with MM. Four hospitals—Imam Khomeini, Rouhani, Shariati, and Sina—were included in the study. All participants in affiliated hospitals underwent Real-time PCR testing to determine whether they had a viral infection with SARS-CoV-2. According to Iranian CDC guidelines, the real-time reverse transcription-polymerase chain reaction (RT-PCR) test was performed on throat specimens using flocked swabs obtained immediately upon admission to confirm SARS-CoV-2 infection. Collaborative clinical virology necessitates the utilization of two pairs of primers, each designed to target two specific genes (the E gene and the RdRP gene).
Results: Patients with MM were found to have a considerably higher risk of hospitalization and mortality from COVID-19, as per the study results. Common symptoms observed in MM patients with COVID-19 included fever (87.5%), cough (87.5%), and dyspnea (62.5%). Moreover, the study revealed a substantial 17-fold increase in the odds of MM patients with COVID-19 positive compared to their counterparts without COVID-19.
Conclusion: The study results emphasize the critical significance of prompt identification of COVID-19 among patients with MM. It underscores the importance of implementing public health measures, vaccination efforts, and continued research to effectively prevent severe illness and fatalities related to COVID-19 within this vulnerable population.
متن کامل [PDF 543 kb]   (188 دریافت)    
نوع مطالعه: پژوهشي | موضوع مقاله: تخصصي
دریافت: 1403/2/12 | پذیرش: 1403/4/19 | انتشار: 1402/3/21
ارسال نظر درباره این مقاله
نام کاربری یا پست الکترونیک شما:

CAPTCHA


XML   English Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghandehari Z, Salahi Ardekani O, Hammami B, Arabi M, Rajabi M, Shivaei S, et al . Clinical Findings and Mortality Rate of Patients with Multiple Myeloma Following COVID-19 infection: Report from Iranian Network for Research in Viral Diseases (INRVD). Iran J Virol 2023; 17 (1) :26-33
URL: http://journal.isv.org.ir/article-1-520-fa.html

Clinical Findings and Mortality Rate of Patients with Multiple Myeloma Following COVID-19 infection: Report from Iranian Network for Research in Viral Diseases (INRVD). مجله ویروس شناسی ایران. 1402; 17 (1) :26-33

URL: http://journal.isv.org.ir/article-1-520-fa.html



بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.
دوره 17، شماره 1 - ( 5-1402 ) برگشت به فهرست نسخه ها
Persian site map - English site map - Created in 0.07 seconds with 37 queries by YEKTAWEB 4710